News
Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and manage conditions such as Type 2 diabetes. However, doctors say there’s a ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
YoCrunch yogurt products are being pulled from store shelves nationwide due to a safety concern -- plastic in the dome -- its ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Albertsons CEO Susan Morris said she had to "double-check the numbers" when she saw how much cottage cheese the chain was selling.
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
Healthy, nutritious foods that are of high quality, taste good, and are satisfying can help people maintain a healthy weight, added Didier. "We already see [our] chefs being excited by the opportunity ...
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...
GLP-1 weight loss drugs have stood at the forefront of industry conversations recently, with concern that the reduced food intake these medications cause may lead to declining sales across the ...
GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all.
The Ohio Department of Administrative Services announced state employees’ Medicaid coverage for GLP-1 obesity management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results